Organometallics

Stability Hygroscopic
Applications Caldiamide Sodium is an analog of Gadodiamide (G125710) which is an apoptosis inducing agent used in chondrocytes. Gadodiamide is primarily used in muscoskeletal diagnosis as a contrast agent.
References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001)

Impurity Iohexol USP Related Compound C
Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.
References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);

Applications Gadoteric Acid is used for magnetic resonance imaging.
References Gheuens, E., et al.: Invest. Radiol., 49, 505-508 (2014)

Applications 2-Fluoro-3-methoxyphenylboronic acid

Applications The (S,S) Oxaliplatin isomer. Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),

Applications Nonionic, dimeric x-ray contrast medium. Diagnostic aid (radiopaque medium).
References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994),

Applications Imaging agent.
References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),

Impurity Iohexol EP Impurity K
Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.

Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),

Stability Hygroscopic
Applications Used as an intermediate in the industrial preparation of non-ionic X-ray contrast agents such as Iohexol (I729500), Ioversol (I737000), Ioxilan (I737500), Iopamidol (I735600).
References Rongved, P., et al.: Carbohydrate Res., 297, 325 (1997),

Impurity Oxaliplatin EP Impurity E
Stability Light Sensitive
Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.
References Gill, D.: Dev. Oncol., 17, 267 (1984);

Stability Hygroscopic
Applications N-Acetyl Cyclized Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.
References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)

Applications Gadodiamide is an apoptosis inducing agent used in chondrocytes. It is primarily used in muscoskeletal diagnosis as a contrast agent.
References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001);

Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.
References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),

Applications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),

Applications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.
References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),

Stability Hygroscopic
Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.
References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),

Stability Hygroscopic
Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.
References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)

Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.
References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);

Applications 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent.
References Petersein, J. et al.: Am. J. Roentgenol., 165, 1167 (1995);

1,1'-Bis{(S)-4,5-dihydro-3H-binaphtho[1,2-c:2',1'-e]phosphino}ferrocene, min. 98% (S,S)-f-Binaphane